Form 4: Hologic CFO Sells Shares for Tax Obligations

Hologic's Chief Financial Officer, Karleen Marie Oberton, disposed of 1,333 shares of common stock to cover tax obligations related to restricted stock unit vesting.

Summary

• Karleen Marie Oberton, Chief Financial Officer of Hologic Inc. (HOLX), reported a transaction involving the company's common stock.
• On November 14, 2025, Ms. Oberton disposed of 1,333 shares of Hologic common stock.
• The disposition was for tax obligations in connection with the settlement of restricted stock units (RSUs) for which service-based vesting requirements had been satisfied.
• The shares were disposed of at a price of $74.15 per share.
• Following this transaction, Ms. Oberton beneficially owns 150,735 shares of Hologic common stock.
• The total beneficial ownership includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction for tax purposes, which is neutral in sentiment. It does not indicate any positive or negative operational or financial developments for the company.

Future Outlook

NA

Industry Context

This is a routine insider transaction related to equity compensation and tax obligations, common across all industries for executives receiving stock-based awards. It does not reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a small, routine transaction for tax purposes by an insider, not a discretionary sale indicating a change in confidence.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of a small number of shares by the CFO to cover tax obligations upon RSU vesting. Such a transaction is a common occurrence for executives with equity compensation and does not provide new information that would warrant a change in investment recommendation. It is not indicative of management's sentiment towards the company's future prospects or a significant shift in ownership. Therefore, a 'hold' recommendation is appropriate as this filing alone does not present a compelling reason to buy or sell.

Keywords

Hologic, HOLX, Karleen Marie Oberton, CFO, Insider Transaction, Form 4, Stock Sale, Tax Withholding, Restricted Stock Units, Equity Compensation